MCID: GNT003
MIFTS: 54

Genital Herpes malady

Infectious diseases, Reproductive diseases categories

Aliases & Classifications for Genital Herpes

About this section

Aliases & Descriptions for Genital Herpes:

Name: Genital Herpes 10 47 12 35 2 65
Herpes Genitalis 10 36
Genital Herpes Simplex 10
 
Virus-Genital Herpes 10
Herpes Genitalia 10
Venereal Herpes 10


Classifications:



External Ids:

Disease Ontology10 DOID:8704
MeSH36 D006558
ICD9CM29 054.10, 054.1
NCIt42 C14364

Summaries for Genital Herpes

About this section
MedlinePlus:35 Genital herpes is a sexually transmitted disease (std) caused by a herpes simplex virus (hsv). it can cause sores on your genital or rectal area, buttocks, and thighs. you can get it from having sex, even oral sex. the virus can spread even when sores are not present. mothers can also infect their babies during childbirth. symptoms of herpes are called outbreaks. you usually get sores near the area where the virus has entered the body. they turn into blisters, become itchy and painful, and then heal. sometimes people do not know they have herpes because they have no symptoms or very mild symptoms. the virus can be more serious in newborn babies or in people with weak immune systems. most people have outbreaks several times a year. over time, you get them less often and the symptoms become milder. the virus stays in your body for life. medicines do not cure genital herpes, but they can help your body fight the virus. this can help lessen symptoms, decrease outbreaks, and lower the risk of passing the virus to others. correct usage of latex condoms can reduce, but not eliminate, the risk of catching or spreading herpes. nih: national institute of allergy and infectious diseases

MalaCards based summary: Genital Herpes, also known as herpes genitalis, is related to acquired immunodeficiency syndrome and pharyngitis, and has symptoms including sores, fever and swollen gl. An important gene associated with Genital Herpes is ACKR1 (Atypical Chemokine Receptor 1 (Duffy Blood Group)), and among its related pathways are IL12 signaling mediated by STAT4 and Cytokines and Inflammatory Response. The drugs interferon alfa-2b and acyclovir have been mentioned in the context of this disorder. Affiliated tissues include genital system, rectum and testes, and related mouse phenotypes are respiratory system and skeleton.

Disease Ontology:10 A herpes simplex that results in infection located in genital system, or located in rectum, has material basis in human herpesvirus 1 or has material basis in human herpesvirus 2, which is transmitted by sexual contact. the infection has symptom sores, has symptom fever, and has symptom swollen glands.

Wikipedia:68 Herpes genitalis (or genital herpes) is a genital infection caused by the herpes simplex virus (HSV). A... more...

Related Diseases for Genital Herpes

About this section

Diseases related to Genital Herpes via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 154)
idRelated DiseaseScoreTop Affiliating Genes
1acquired immunodeficiency syndrome30.9CCL5, IL10
2pharyngitis30.3CCL5, IL10
3polyradiculopathy30.1CCL5, IL10, TBX21
4herpes simplex11.2
5reproductive system disease10.7
6female reproductive system disease10.7
7male reproductive system disease10.7
8sexual disorder10.7
9male genital disorders10.7
10viral infectious disease10.6
11human immunodeficiency virus infectious disease10.5
12skin conditions10.5
13skin disease10.5
14vaginitis10.5
15hiv-110.4
16neonatal herpes10.4
17ipex syndrome10.4
18child syndrome10.3
19chancroid10.3
20herpes zoster10.3
21nutritional deficiency disease10.3
22syphilis10.3
23kid syndrome10.3
24thalamic neoplasm10.3CCL5, IL4
25benign deep fibrous histiocytoma10.3CCL5, IL4
26chronic cystitis10.3CCL5, IL4
27verrucous nevus acanthokeratolytic10.3CCL5, IL4
28hyper-reninism10.2IL4, TLR2
29epithelioid malignant peripheral nerve sheath tumor10.2CCL5, IL4
30primary progressive freezing gait10.2IL10, IL4
31sensorineural hearing loss10.2IL10, IL4
32chronic lymphocytic leukemia10.2
33leukemia10.2
34lymphogranuloma venereum10.2
35aphthous stomatitis10.2
36gonorrhea10.2
37meningitis10.2
38urticaria10.2
39intrapelvic lymph node leukemic reticuloendotheliosis10.2IL10, IL4
40early myoclonic encephalopathy10.2IL10, IL4
41neurotic excoriation10.2IL10, IL4
42buruli ulcer10.2IL10, IL4
43polycythemia10.2IL10, IL4
44stalker chitayat syndrome10.2CCL5, IL18
45pulmonary large cell neuroendocrine carcinoma10.2CCL5, IL4
46potter's syndrome10.2IL10, IL4
47colitis10.2IL10, IL4
48rasmussen johnsen thomsen syndrome10.2IL18, IL4
49human granulocytic anaplasmosis10.2CCL5, IL18
50craniosynostosis 310.2CCL5, IL10

Graphical network of the top 20 diseases related to Genital Herpes:



Diseases related to genital herpes

Symptoms for Genital Herpes

About this section

Symptoms:

 10
  • sores
  • fever
  • swollen gl

Drugs & Therapeutics for Genital Herpes

About this section

Drugs for Genital Herpes (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MetronidazoleapprovedPhase 4389443-48-14173
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-Methyl-5-nitro-1-imidazoleethanol
2-Methyl-5-nitroimidazole-1-ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
AKOS000269646
APMN
ARONIS24285
Acromona
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAS 02983617
BAY-5360
BCBcMAP01_000184
BIDD:GT0107
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
Bayer 5360
Bexon
Bio-0694
CAS-443-48-1
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
CONT
CPD000058175
Caswell No. 579AA
Clont
D00409
DB00916
Danizol
Deflamon
Deflamon-wirkstoff
DivK1c_000007
EINECS 207-136-1
EPA Pesticide Chemical Code 120401
Efloran
Elyzol
Entizol
Eumin
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
METRO I.V
METRONIDAZOLE USP
MLS000028590
MLS000758286
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
Metric
Metric 21
Metro Cream
Metro Gel
 
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
MetroGel
MetroGel-Vaginal
MetroLotion
Metrocream
Metrodzhil
Metrogel
Metrogel-vaginal
Metrogel-vaginal (TN)
Metrogyl
Metrolag
Metrolotion
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
Metronidazole
Metronidazole (JP15/USP/INN)
Metronidazole Benzoate
Metronidazole Monohydrochloride
Metronidazole Phosphoester
Metronidazole Topical Gel
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole hydrochloride
Metronidazole in Plastic Container
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
NIDA
NINDS_000007
NSC 50364
NSC 69587
NSC-50364
NSC50364
NSC69587
Nalox
Nidagel
Noritate
Noritate (TN)
Novonidazol
Orvagil
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Prestwick_334
Protostat
RP 8823
RP-8823
Rathimed
Rosadan
Rosased
S1907_Selleck
SAM001247010
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
SPECTRUM1500412
STK177359
Sanatrichom
Satric
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
Spectrum_001035
Takimetol
Trichazol
Trichex
Tricho cordes
Tricho-gynaedron
Trichocide
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Wagitran
ZERO/004064
ZINC00113442
Zadstat
Zidoval
giniflavir
metronidazole
neo-Tric
2
FamciclovirapprovedPhase 4, Phase 318104227-87-43324
Synonyms:
1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)
104227-87-4
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester)
2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate
2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate
9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine
9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
AC-11064
AC1L1FOB
Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester
Anti-Farnesyl Rabbit pAb
BRD-K45033733-001-02-3
BRL 42810
BRL-42810
BSPBio_003489
Bio-0039
C14H19N5O4
CHEBI:4974
CHEMBL880
CID3324
CPD000466375
D00317
DB00426
Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine
FCV
Famciclovir
Famciclovir (JAN/USAN/INN)
Famciclovir [USAN:BAN:INN]
Famciclovirum
Famciclovirum [INN-Latin]
Famvir
 
Famvir (TN)
HMS1922L09
HMS2051G22
HMS2090G10
HMS2093K12
I03-0096
IN1338
KBio2_000946
KBio2_003514
KBio2_006082
KBio3_002709
KBioGR_001162
KBioSS_000946
LS-120147
MLS000759505
MLS001424115
MolPort-003-666-602
NCGC00095133-01
NCGC00095133-02
NCGC00095133-03
Oravir
S2467_Selleck
SAM001246732
SMR000466375
SPBio_001202
SPECTRUM1505201
STK623204
Spectrum2_001101
Spectrum3_001675
Spectrum4_000611
Spectrum5_001548
Spectrum_000466
UNII-QIC03ANI02
ZINC01530635
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
famciclovir
3
Tenofovirapproved, investigationalPhase 4636147127-20-6464205
Synonyms:
(R)-9-(2-Phosphonomethoxypropyl)adenine
(R)-9-(2-Phosphonylmethoxypropyl)adenine
(R)-PMPA
147127-20-6
206184-49-8
AC-760
AC1LA9BO
Anh. tenofovir
Anhydrous tenofovir
Apropovir
CHEBI:45809
CHEMBL483
CID464205
D,L-Tenofovir
DB00300
GNA & Tenofovir
GS 1275
GS 1278
GS1278
HHA & Tenofovir
 
KS-5021
MolPort-003-850-411
NCGC00167535-01
PMPA
PMPA-(R)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI)
Phosphonic acid, [[2-(6-amino-9H-purin-9
S1401_Selleck
TDF
TFV
Tenefovir
Tenofovir
Tenofovir (anh.)
Tenofovir Disoproxil Fumarate
Tenofovir disoproxil
Tenofovir disoproxil fumarate
UNII-99YXE507IL
Viread
Viread, Tenofovir
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
4AcyclovirPhase 4, Phase 3, Phase 2, Phase 1149
5valacyclovirPhase 4, Phase 3, Phase 2, Phase 198
6
Tenofovir disoproxilPhase 4636201341-05-15481350
Synonyms:
201341-05-1
9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine
9-[(R)-2-[[Bis[[(isopropoxycarbonyl)oxy] methoxy]phosphinyl]methoxy]propyl]adenine
AC1NUKHG
Bis(POC)PMPA
Bis(isopropyloxymethylcarbonyl) 9-(2-phosphonomethoxypropyl)adenine
Bis(isopropyloxymethylcarbonyl)PMPA
CHEMBL1538
 
CID5481350
GS 4331-05 (*1:1 Fumarate salt*)
LS-187012
LS-187786
PMPA prodrug
ST51052782
TDF
Tenofovir disoproxil
Viread(TM) (*1:1 Fumarate salt*)
[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
7KrestinPhase 3, Phase 2184
8Monophosphoryl lipid APhase 317
9Aluminum sulfatePhase 377
102-AminopurinePhase 312
11
Imiquimodapproved, investigationalPhase 212699011-02-657469
Synonyms:
1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine
1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine
1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
3M Brand of Imiquimod
4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline
99011-02-6
AC-529
AC1L1N2I
AC1Q4YO9
Aldara
Aldara (TN)
Aldara, Imiquimod
BB_SC-2107
BIDD:GT0859
Beselna
C056493
CHEBI:36704
CHEMBL1282
CID57469
D02500
DB00724
DZ-2636
FT-0080222
HMS2090M14
 
I06-0624
I06-2289
I0747
I5159_SIGMA
IMIQUIMOD
Imiquimod
Imiquimod (JAN/USAN/INN)
Imiquimod [USAN:INN]
Imiquimod acetate
Imiquimodum
LS-178395
MLS000083577
MTD-39
MolPort-002-507-845
NCGC00070736-02
NSC369100
R 837
R-837
S 26308
S-26308
S1211_Selleck
SMR000048307
STK583860
TL8006059
TMX-101
UNII-P1QW714R7M
Vyloma
ZINC19632912
Zartra
Zyclara
12
Ganciclovirapproved, investigationalPhase 213982410-32-03454
Synonyms:
106931-35-5
107910-75-8 (mono-hydrochloride salt)
2'-NDG
2'-Nor-2'-deoxyguanosine
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol
2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one
2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one
2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one
82410-32-0
86357-12-2
9-((1,3-Dihydroxy-2-propoxy)methyl)guanine
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine
9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE
9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine
9-[(1,3-dihydroxy-2-propoxy)methyl]guanine
96551-29-0
AC-12604
AC1L1FZ2
AC1Q52OB
AKOS004119898
BB_NC-1042
BIDD:GT0783
BIOLF-62
BPBio1_000877
BSPBio_000797
BW 759
BW 759U
BW-759U
BW-795
BW-B 759U
Biolf 62
CAS-82410-32-0
CCRIS 9212
CHEBI:465284
CHEMBL182
CID3454
CPD000058324
Citovirax
Cymevan
Cymeven
Cymevene
Cytovene
Cytovene (TN)
Cytovene IV
Cytovene-IV
D00333
DB01004
DRG-0018
EU-0100539
 
G 2536
G2536_SIGMA
GA2
GANCICLOVIR SODIUM
GCV & 1110U81
GCV & MSL
Ganciclovir
Ganciclovir & C34-dgA immunotoxin
Ganciclovir & D5-dgA immunotoxin
Ganciclovir (JAN/USP/INN)
Ganciclovir Sodium
Ganciclovir [USAN:INN:BAN:JAN]
Ganciclovirum
Ganciclovirum [Latin]
Gancyclovir
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody
HHEMG
HMS1570H19
HMS2090K08
HSDB 6512
Hydroxyacyclovir
I07-0010
IN1478
LS-73939
Lopac-G-2536
Lopac0_000539
MB3795
MLS000028481
MLS001077349
MolPort-000-758-398
MolPort-002-507-301
NCGC00015471-01
NCGC00015471-02
NCGC00015471-03
NCGC00015471-06
NCGC00093928-01
NCGC00093928-02
NCGC00168567-01
PDSP1_000816
PDSP2_000803
Prestwick0_000839
Prestwick1_000839
Prestwick2_000839
Prestwick3_000839
Prestwick_1068
RS-21592
SAM002548936
SMP2_000038
SMR000058324
SPBio_002718
ST-605
STK801910
UNII-P9G3CKZ4P5
Virgan
Vitrasert
Vitrasert (TN)
ZINC00001505
Zirgan
ganciclovir
nchembio.87-comp3
13
QS 21Phase 238141256-04-4
Synonyms:
 
Stimulon
14Freund's AdjuvantPhase 293
15LecithinNutraceuticalPhase 257
16
Methadoneapproved29676-99-34095
Synonyms:
(+)-Methadone
(+-)-Methadone
(+/-)-Methadone
(+/-)-Methadone hydrochloride
(+/-)-Tussal
(-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(-)-Methadone
(6R)-Methadone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone
(S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(±)-methadone
1095-90-5 (hydrochloride)
297-88-1
3-14-00-00278 (Beilstein Handbook Reference)
3-14-00-00279 (Beilstein Handbook Reference)
3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI)
5653-80-5
6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture
6-(dimethylamino)-4,4-diphenylheptan-3-one
6-Dimethylamino-4,4-diphenyl-3-heptanone
6-dimethylamino-4,4-di(phenyl)heptan-3-one
6S-Methadone
76-99-3
A 4624
AC-16055
AC1L1HEG
AC1Q2RLW
AN 148
AN-148 (*Hydrochloride*)
Adanon
Adanon hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose
Althose hydrochloride
Amidon
Amidone
BRN 3213667
BRN 3213668
BRN 3213669
Biscuits
Butalgin
C07163
CHEBI:6807
CHEMBL651
CID4095
D08195
DB00333
DEA No. 9250
DL-Methadone hydrochloride
Depridol
Dextromethadone
Diaminon
Diaminon hydrochloride
Diskets
DivK1c_000963
Dl-Methadone
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine (*Hydrochloride*)
Dolophine HCL
EINECS 200-996-9
Fenadon
Fenadone
 
Fenadone (*Hydrochloride*)
HSDB 3119
Heptadon
Heptadone
Heptadone (*Hydrochloride*)
Heptanon
Heptanon (*Hydrochloride*)
Heptanon (pharmaceutical)
Hoechst 10820
Hoescht 10820 (*Hydrochloride*)
IDI1_000963
K 174
KBio1_000963
Ketalgin
Ketalgin hydrochloride
L-(+)-Methadone
L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
L-Polamidon
L000874
LS-74485
LS-74486
LS-74487
Levometadona
Levometadona [INN-Spanish]
Levomethadone [INN]
Levomethadonum
Levomethadonum [INN-Latin]
Levothyl
Mecodin
Mephenon
Metadona
Metadona [INN-Spanish]
Metadona [Spanish]
Metadone
Metadone [DCIT]
Metasedin
Methadon
Methadona
Methadona [Spanish]
Methadone (BAN)
Methadone HCL
Methadone HCL Intensol
Methadone Hydrochloride
Methadone M
Methadone [INN:BAN]
Methadone hydrochloride
Methadonum
Methadonum [INN-Latin]
Methadonum [Latin]
Methadose
Methaquaione
Miadone
Moheptan
MolPort-001-785-650
NINDS_000963
Phenadone
Phenadone (*Hydrochloride*)
Phenadone hydrochloride
Physeptone
Polamidon
Polamidone
Polamivet
Racemic methadone
S-(+)-Methadone
Sedo-Rapide
Tussol
UNII-UC6VBE7V1Z
Westadone
d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
d-Methadone
dl-Methadone
l-Methadone
l-Polamivet
methadone
17
Emtricitabineapproved, investigational381143491-57-060877
Synonyms:
(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-.beta.-L-FTC
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine
(-)-FTC
(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
(2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
.beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine
143491-54-7
143491-57-0
145213-48-5
2',3',5-FTC
2',3'-Dideoxy-5-fluoro-3'-thiacytidine
2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine
2'-Deoxy-5-fluoro-3'-thiacytidine
2-FTC
3'-Thia-2'.3'-dideoxy-5-fluorocytidine
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine
524W91
AC1L1U3I
AC1Q4KUB
BW 1592
 
BW 524W91
BW-524W91
BW524W91
C122114
C12599
C8H10FN3O3S
CHEBI:31536
CHEMBL885
CID60877
Coviracil
Coviracil(TM)
D01199
DB00879
DRG-0208
Emtricitabin
Emtricitabina
Emtricitabine
Emtricitabine (JAN/USAN/INN)
Emtricitabinum
Emtriva
Emtriva (TN)
Emtriva(TM)
FT-0080009
HMS2089I05
HSDB 7337
LS-135838
LS-173184
NCGC00164564-01
RCV
Racivir
SBB066061
TL8000958
UNII-G70B4ETF4S
ZINC03629271
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
dOTFC
emtricitabine
18
Ampicillinapproved5069-53-46249
Synonyms:
(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
1h8s
33604-21-6
37234-64-3
47355-94-2
50584-05-9
6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid
6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-(a-Aminophenylacetamido)penicillanic acid
6-D(-)-alpha-Aminophenylacetamido-penicillanic acid
6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
69-52-3 (mono-hydrochloride salt)
69-53-4
6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
7177-48-2 (TRIHYDRATE)
800-79-3
8056-87-9
96707-69-6
98520-55-9
A9393_SIGMA
AB-PC
AB-PC Sol
ABPC
AC-14075
AC1L1M46
AMP
AMPI
AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2)
AP
AY 6108
AY 6108
AY-6108
Acillin
Adobacillin
Alpen
Amblosin
Amcill
Amfipen
Amfipen V
Amfipen v
Aminobenzylpenicillin
Amipenix S
Ampen
Ampi-Co
Ampi-Tab
Ampi-bol
Ampi-co
Ampi-tab
Ampichel
Ampicil
Ampicilina
Ampicilina [INN-Spanish]
Ampicillin
Ampicillin (USP/INN)
Ampicillin A
Ampicillin Acid
Ampicillin Anhydrate
Ampicillin Anhydrous
Ampicillin Base
Ampicillin Sodium
Ampicillin Trihydrate
Ampicillin [USAN:BAN:INN:JAN]
Ampicillin [USAN:INN:BAN:JAN]
Ampicillin [Usan:Ban:Inn:Jan]
Ampicillin acid
Ampicillin anhydrate
Ampicillin sodium
Ampicillina
Ampicillina [DCIT]
Ampicillina [Dcit]
Ampicilline
Ampicilline [INN-French]
Ampicillinum
Ampicillinum [INN-Latin]
Ampicin
Ampifarm
Ampikel
Ampimed
Ampipenin
Ampipenin, nt3
Ampiscel
Ampisyn
Ampivax
Ampivet
Amplacilina
Amplin
Amplipenyl
Amplisom
Amplital
Ampy-Penyl
Anhydrous Ampicillin
Anhydrous ampicillin
Anhydrous ampicillin (JP15)
Austrapen
BA 7305
BIDD:GT0184
BPBio1_000142
BRL 1341
BRL-1341
BSPBio_000128
BSPBio_001862
Bayer 5427
Binotal
Bonapicillin
Britacil
C06574
CHEBI:28971
CHEBI:53713
CHEMBL174
CID6249
Campicillin
Cimex
Copharcilin
D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid
D-(-)-6-(alpha-aminophenylacetamido)penicillanic acid
D-(-)-Ampicillin
D-(-)-alpha-Aminobenzylpenicillin
D-(-)-alpha-Aminopenicillin
D-(-)-ampicillin
D-(−)-6-(α-aminophenylacetamido)penicillanic acid
D-(−)-ampicillin
D-Ampicillin
D-Cillin
D-a-Aminobenzylpenicillin
D00204
DB00415
Delcillin
Deripen
 
DivK1c_000466
Divercillin
Doktacillin
Duphacillin
EINECS 200-709-7
Geocillin
Grampenil
Guicitrina
Guicitrine
HI 63
HMS2090I11
HSDB 3009
IDI1_000466
KBio1_000466
KBio2_000430
KBio2_002998
KBio2_005566
KBio3_001362
KBioGR_000598
KBioSS_000430
KS-R1
LS-1586
LS-169948
Lifeampil
MLS000028405
MLS001074168
Magnapen
Marcillin
MolPort-001-794-635
Morepen
NCGC00023282-05
NCGC00023282-06
NINDS_000466
NSC 528986
NSC-528986
NSC528986
Norobrittin
Novo-ampicillin
Nuvapen
OMNIPEN (AMPICILLIN)
Olin Kid
Olin kid
Omnipen
Omnipen (TN)
Omnipen-N
Orbicilina
P 50
P-50
Pen A
Pen A Oral
Pen Ampil
Pen a
Pen ampil
Penbristol
Penbritin
Penbritin paediatric
Penbritin syrup
Penbritin-S
Penbrock
Penicillin, Aminobenzyl
Penicline
Penimic
Pensyn
Pentrex
Pentrexl
Pentrexyl
Pentritin
Pfizerpen A
Pfizerpen a
Pfizerpen-A
Polycillin
Polycillin-N
Polyflex (Veterinary)
Ponecil
Prestwick0_000114
Prestwick1_000114
Prestwick2_000114
Prestwick3_000114
Princillin
Principen
Principen '125'
Principen '250'
Principen '500'
QIDamp
Qidamp
Racenacillin
Ro-Ampen
Ro-ampen
Rosampline
Roscillin
SBB063111
SK-Ampicillin
SK-ampicillin
SMP1_000211
SMR000058352
SPBio_000818
SPBio_002067
SQ 17382
Semicillin
Semicillin R
Servicillin
Spectrum2_000769
Spectrum3_000301
Spectrum4_000149
Spectrum5_000814
Spectrum_000050
Sumipanto
Supen
Synpenin
Texcillin
Tokiocillin
Tolomol
Totacillin
Totacillin (sodium)
Totacillin-N
Totalciclina
Totapen
Trifacilina
UNII-7C782967RD
Ukapen
Ultrabion
Ultrabron
Vampen
Viccillin
Viccillin S
Vidocillin
Vidopen
WY-5103
Wypicil
alpha-Aminobenzylpenicillin
ampicillanyl
ampicillin
anhydrous ampicillin
19Emetics159

Interventional clinical trials:

(show top 50)    (show all 92)
idNameStatusNCT IDPhase
1A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed PatientsCompletedNCT00158860Phase 4
2Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black PatientsCompletedNCT00477334Phase 4
3A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus SheddingCompletedNCT00129818Phase 4
4RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With FamciclovirCompletedNCT00219310Phase 4
5Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIVCompletedNCT00527618Phase 4
6VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive SubjectsCompletedNCT00116844Phase 4
7VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2CompletedNCT00306293Phase 4
8Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) SheddingCompletedNCT01448616Phase 4
9Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2CompletedNCT00362297Phase 4
10A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, ThailandCompletedNCT00362596Phase 4
11Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding StudyCompletedNCT00464542Phase 4
12Effect of HSV-2 Suppressive Therapy on Sexual BehaviorActive, not recruitingNCT00495716Phase 4
13Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2Active, not recruitingNCT01346475Phase 4
14A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 ReactivationActive, not recruitingNCT00723229Phase 4
15A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected PersonsTerminatedNCT00079911Phase 4
16Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital HerpesCompletedNCT00306787Phase 3
17Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital HerpesCompletedNCT00171990Phase 3
18Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes DiseaseCompletedNCT00699764Phase 3
19Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital HerpesCompletedNCT01281007Phase 3
20A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
21HerpeVac Trial for Young WomenCompletedNCT00057330Phase 3
22Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV InfectionCompletedNCT00262106Phase 3
23Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3
24Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative SubjectsCompletedNCT00698568Phase 3
25Valaciclovir to Prevent Transmission of Herpes Simplex VirusCompletedNCT00001649Phase 3
26Episodic Acyclovir Therapy for Genital UlcersCompletedNCT00164424Phase 2, Phase 3
27HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsCompletedNCT00465205Phase 3
28HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.CompletedNCT00378976Phase 3
29Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk PopulationsCompletedNCT00710060Phase 3
30A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsActive, not recruitingNCT00005663Phase 3
31Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the CommunityActive, not recruitingNCT00124878Phase 3
32Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?Active, not recruitingNCT00860977Phase 3
33Open-label Study of ASP2151 in Herpes Simplex PatientsActive, not recruitingNCT02209324Phase 3
34Effect of Male Circumcision on HIV Incidence (ANRS 1265)TerminatedNCT00122525Phase 3
35A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedNCT00486200Phase 2
36Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV SheddingCompletedNCT00158509Phase 2
37Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital HerpesCompletedNCT01687595Phase 2
38Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)CompletedNCT00158483Phase 2
39Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2CompletedNCT01047540Phase 2
40Safety and Immunogenicity Study of Therapeutic HSV-2 VaccineCompletedNCT01667341Phase 1, Phase 2
41Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in UgandaCompletedNCT00405821Phase 2
42Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.CompletedNCT00740584Phase 1, Phase 2
43Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideCompletedNCT00213031Phase 2
44HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and BreastfeedingCompletedNCT00530777Phase 2
45BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2
46Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaCompletedNCT00273910Phase 2
47HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate CancerRecruitingNCT01913106Phase 1, Phase 2
48Evaluating New Formulation of Therapeutic HSV-2 VaccineActive, not recruitingNCT02515175Phase 2
49Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsActive, not recruitingNCT02030301Phase 1, Phase 2
50Dose Ranging Safety and Efficacy of Therapeutic HSV-2 VaccineActive, not recruitingNCT02114060Phase 2

Search NIH Clinical Center for Genital Herpes

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: Herpes Genitalis

Genetic Tests for Genital Herpes

About this section

Anatomical Context for Genital Herpes

About this section

MalaCards organs/tissues related to Genital Herpes:

33
Testes, T cells, Skin, Nk cells, B cells, Cervix, Myeloid

FMA organs/tissues related to Genital Herpes:

16
Genital system, Rectum

Animal Models for Genital Herpes or affiliated genes

About this section

MGI Mouse Phenotypes related to Genital Herpes:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.5APOE, IL10, IL4, TBX21, TLR2
2MP:00053908.2ACKR1, APOE, IL10, IL4, T, TLR2
3MP:00107717.9APOE, IL10, IL18, IL4, T, TLR2
4MP:00053817.7APOE, IL10, IL18, IL4, T, TBX21
5MP:00053977.6APOE, CCL5, IL10, IL18, IL4, TBX21
6MP:00036317.4APOE, IL10, IL18, IL4, T, TBX21
7MP:00053877.1ACKR1, APOE, CCL5, IL10, IL18, IL4
8MP:00053767.0ACKR1, APOE, IL10, IL18, IL4, T

Publications for Genital Herpes

About this section

Articles related to Genital Herpes:

(show top 50)    (show all 533)
idTitleAuthorsYear
1
Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs. (26149263)
2015
2
Chancroid, lymphogranuloma venereum, granuloma inguinale, genital herpes simplex infection, and molluscum contagiosum. (24559566)
2014
3
Status of prophylactic and therapeutic genital herpes vaccines. (24631871)
2014
4
Prevalence of Trichomoniasis, Vaginal Candidiasis, Genital Herpes, Chlamydiasis, and Actinomycosis among Urban and Rural Women of Haryana, India. (26316979)
2014
5
Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis. (25505043)
2014
6
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection. (22398318)
2012
7
Looking for an asymptomatic infection: usefulness of screening for Chlamydia trachomatis and genital herpes. (23007249)
2012
8
Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. (21714324)
2011
9
Clarification in law is sought after man is jailed for infecting partner with genital herpes. (21859791)
2011
10
Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes. (21869749)
2011
11
Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy? (19753286)
2009
12
New concepts in understanding genital herpes. (19857385)
2009
13
Comparison of nested-polymerase chain reaction and virus culture for the diagnosis of genital herpes simplex virus infection. (18581019)
2008
14
Is suspicion of genital herpes infection associated with avoiding sex? A clinic-based study. (18771644)
2008
15
Knowledge about genital herpes amongst first time attenders at a department of genitourinary medicine. (18422207)
2008
16
Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial. (18621575)
2008
17
Managing genital herpes infections in pregnancy. (17375803)
2007
18
Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. (17267483)
2007
19
Genital herpes and its management. (17510153)
2007
20
Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life. (17065847)
2007
21
Genital herpes in Africa: time to rethink treatment. (18156037)
2007
22
Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes. (16957911)
2007
23
Adolescents anticipated experience of screening for genital herpes. (16895656)
2006
24
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes. (16421805)
2006
25
National survey of diagnostic services for genital herpes. (16061538)
2005
26
The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies. (16282463)
2005
27
Genital herpes. (16620476)
2005
28
Counseling the patient who has genital herpes or genital human papillomavirus infection. (15963883)
2005
29
Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection. (16272337)
2005
30
Genital herpes: common but misunderstood. Don't assume that genital herpes isn't your concern. (16435436)
2005
31
Genital herpes. (15652098)
2004
32
Expert commentary: genital herpes transmission. (15955269)
2004
33
The theoretical basis of stigma as applied to genital herpes. (15115630)
2004
34
Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. (15295125)
2004
35
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials. (15931690)
2003
36
Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia. (18159431)
2003
37
Progress in meeting today's demands in genital herpes: an overview of current management. (12353187)
2002
38
Genital herpes. (11991914)
2002
39
Psychosocial outcomes in individuals living with genital herpes. (12353728)
2002
40
Imiquimod and genital herpes. (11939822)
2002
41
The ratio of cytokine levels in genital herpes during various phases of infection. (11687847)
2001
42
Patients' perspectives on the burden of recurrent genital herpes. (11564330)
2001
43
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. (10797375)
2000
44
Improving the care of patients with genital herpes. (10977846)
2000
45
Cooperative agreements for strategies to prevent genital herpes infections: building a national prevention program, notice of availability of funds. Centers for Disease Control and Prevention. (10558529)
1999
46
Medication tames genital herpes. (14612772)
1999
47
Quality of life and use of health care among people with genital herpes in France. (10494718)
1999
48
Valaciclovir: new indications. In genital herpes: simpler administration. (10557565)
1999
49
Undocumented history of maternal genital herpes followed by neonatal herpes meningitis. (8064427)
1994
50
Psychological investigation of genital herpes recurrence: prospective assessment and cognitive-behavioral intervention for a chronic physical disorder. (3383831)
1988

Variations for Genital Herpes

About this section

Expression for genes affiliated with Genital Herpes

About this section
Search GEO for disease gene expression data for Genital Herpes.

Pathways for genes affiliated with Genital Herpes

About this section

Pathways related to Genital Herpes according to GeneCards Suite gene sharing:

(show all 17)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.7IL18, TBX21
29.7IL10, IL4
39.7IL10, IL4
49.6IL10, IL18
5
Show member pathways
9.4IL18, IL4, TBX21
69.4CCL5, IL18, TLR2
7
Show member pathways
9.3IL10, IL4, TLR2
8
Show member pathways
9.3IL10, IL18, IL4
99.2IL10, IL18, TLR2
10
Show member pathways
9.2GH2, IL10, IL4
11
Show member pathways
9.0CCL5, IL18, IL4, TLR2
129.0ACKR1, IL10, IL18, TLR2
13
Show member pathways
8.9IL10, IL18, TBX21, TLR2
148.7CCL5, IL10, IL4, TBX21, TLR2
15
Show member pathways
8.6IL10, IL18, IL4, TBX21, TLR2
16
Show member pathways
8.4CCL5, GH2, IL10, IL18, IL4
17
Show member pathways
8.1CCL5, GH2, IL10, IL18, IL4, TLR2

GO Terms for genes affiliated with Genital Herpes

About this section

Cellular components related to Genital Herpes according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055767.5APOE, CCL5, GH2, IL18, IL4, PI3

Biological processes related to Genital Herpes according to GeneCards Suite gene sharing:

(show all 22)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of isotype switching to IgG isotypesGO:004830410.3IL4, TBX21
2positive regulation of MHC class II biosynthetic processGO:004534810.3IL10, IL4
3regulation of isotype switchingGO:004519110.2IL10, IL4
4positive regulation of NF-kappaB import into nucleusGO:004234610.2IL18, TLR2
5negative regulation of endothelial cell apoptotic processGO:200035210.2IL10, IL4
6negative regulation of interleukin-12 productionGO:003269510.2IL10, TLR2
7positive regulation of activated T cell proliferationGO:004210410.2IL18, IL4
8positive regulation of cytokine secretionGO:005071510.2IL10, TLR2
9negative regulation of nitric oxide biosynthetic processGO:004501910.2IL10, IL4
10defense response to protozoanGO:004283210.1IL10, IL4
11positive regulation of JAK-STAT cascadeGO:004642710.1CCL5, IL10
12negative regulation of growth of symbiont in hostGO:004413010.0IL10, TLR2
13negative regulation of neuron deathGO:190121510.0APOE, CCL5
14lipopolysaccharide-mediated signaling pathwayGO:00316639.9CCL5, IL18, TLR2
15type 2 immune responseGO:00420929.9IL10, IL18, IL4
16positive regulation of inflammatory responseGO:00507299.8CCL5, IL18, TLR2
17response to activityGO:00148239.7CCL5, IL10
18response to bacteriumGO:00096179.7CCL5, TLR2
19cellular response to lipopolysaccharideGO:00712229.5CCL5, IL10, IL18
20regulation of neuron deathGO:19012149.3APOE, CCL5
21inflammatory responseGO:00069548.8ACKR1, CCL5, IL10, IL18, TLR2
22immune responseGO:00069558.6CCL5, IL10, IL18, IL4, TLR2

Molecular functions related to Genital Herpes according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051259.3IL10, IL18, IL4

Sources for Genital Herpes

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet